newsfilter
← Latest News
GlobeNewswire·

Celularity Files Appeal Request and Amended Compliance Plan with Nasdaq Hearings Panel

FLORHAM PARK, N.J., Oct. 23, 2024 (GLOBE NEWSWIRE) -- Celularity Inc. (NASDAQ:CELU) ("Celularity"), a regenerative and cellular medicine company, today announced that it has requested a hearing before the Nasdaq